ETFs Are Net Sellers of Option Care Health (OPCH) on Friday
This article first appeared on GuruFocus.
ETF flows out of Option Care Health stretched to a third straight day of net selling on Friday, when funds sold $10.0 million of the stock. That followed net selling of $15.9 million on Thursday and $21.0 million on Wednesday. More ETFs traded the other way on Friday, with 12 buying versus 8 selling, but the sellers moved larger amounts. The stock is held by 52 ETFs that did not trade it.
Looking for a fund? Use the ETF Screener, and follow daily fund activity on the ETF Trends page.
For the full record of ETF and guru buying and selling in OPCH, see the OPCH guru trades page.
Which ETFs sold OPCH on Friday?
The largest sellers by dollar value were DFAT ($9.2 million), IWM ($0.4 million) and DFUS ($0.2 million). In all, 12 ETFs added shares and 8 cut them.
DFAT accounted for the bulk of the move, cutting its stake by 31.5% through a 289,338-share reduction worth $9.2 million. IWM trimmed 13,536 shares for $0.4 million, while DFUS and DFAU each shed about $0.2 million and DCOR and MDY each shed $0.2 million and $0.1 million respectively. Option Care Health sits in the Healthcare sector and the Medical Care Facilities industry, with a market cap of $4.8 billion.
Have ETFs been buying or selling OPCH lately?
Over the last 5 reported days, ETFs were net buyers on 0 and net sellers on 4, so the recent trend is mostly selling.
What does OPCH do?
Option Care Health Inc. is a U.S.-based provider of home and alternate-site infusion therapy services. The company delivers intravenous and subcutaneous medications, nursing care, and related clinical support to patients with chronic and acute conditions, including bleeding disorders, neurological disorders, heart failure, infections requiring anti-infectives, and chronic inflammatory diseases.
Option Care Health reported trailing-12-month revenue of $5.75 billion, up 11.1% over the year. Gross margin was 17.9% and net margin 3.7%. The stock trades at a P/E of 22.88, a P/B of 3.59 and a P/S of 0.86, against a market cap of $4.8 billion. Its GF Score is 88, and at $31.71 the price sits below the GF Value of $38.73. The shares are down 0.47% year to date.